AP NEWS

G Medical Engages US Underwriter to Manage Dual-Listing on NASDAQ

October 2, 2018

SYDNEY--(BUSINESS WIRE)--Oct 2, 2018--Mobile and e-Health company G Medical Innovations (ASX: GMV) (“G Medical” or the “Company”) has today engaged a New York based Underwriter, to assist in the processes towards a US Public Offering via the NASDAQ Stock Exchange.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181002005846/en/

G Medical Innovations Structure (Graphic: Business Wire)

The Company will remain listed on the Australian Stock Exchange, and the management of G Medical have engaged an Underwriter who will now proceed with submission of the F-1 Registration Statement with all parties working towards a US listing within the next 4 to 5 months.

G Medical cautions investors that there can be no certainty that the proposed US listing will proceed. Investors should note that the listing is subject to satisfaction of all legal and regulatory requirements with NASDAQ, SEC and ASX, as well as any shareholder approvals that may be required under the ASX Listing Rules.

Shareholders will be updated throughout the process as appropriate, and the amount of capital to be raised will be determined closer to the proposed offering.

About G Medical Innovations

G Medical (ASX: GMV) was founded in August 2014, aiming to be at the forefront of the digital health revolution, developing the next generation of mobile health (mHealth) technologies. The Company leverages the experience and expertise of its Board to deliver best-in-class solutions to address this global opportunity.

The Company specialises in innovative next generation mobile and e-health solutions and services using its suite of devices and software solutions with a view to driving multiple and recurring revenue streams, across numerous verticals and territories.

For more information on G Medical, please visit  www.gmedinnovations.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181002005846/en/

CONTACT: Corporate Advisors

Otsana Capital

108 Outram Street

West Perth WA 6005

Telephone: +61 8 9486 7244

www.otsana.com

or

Investor Relations

Viriathus Australia

Level 8/525 Flinders Street

Melbourne VIC 3000

Telephone: +61 2 8667 5360

www.viriathus.com

or

Media Enquiries

Closer Communications

David Wolf

Telephone: + 61 411 111 787

david@closer.com.au

KEYWORD: AUSTRALIA UNITED STATES NORTH AMERICA AUSTRALIA/OCEANIA NEW YORK

INDUSTRY KEYWORD: TECHNOLOGY SOFTWARE TELECOMMUNICATIONS HEALTH MOBILE/WIRELESS GENERAL HEALTH

SOURCE: G Medical

Copyright Business Wire 2018.

PUB: 10/02/2018 12:08 PM/DISC: 10/02/2018 12:08 PM

http://www.businesswire.com/news/home/20181002005846/en

AP RADIO
Update hourly